Paul C. Grint
2018 - AmpliPhi Biosciences
In 2018, Paul C. Grint earned a total compensation of $618K as Former Chief Executive Officer at AmpliPhi Biosciences, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,000 |
|---|---|
| Salary | $475,000 |
| Total | $618,000 |
Grint received $475K in salary, accounting for 77% of the total pay in 2018.
Grint also received $143K in non-equity incentive plan.
Rankings
In 2018, Paul C. Grint's compensation ranked 11,178th out of 14,244 executives tracked by ExecPay. In other words, Grint earned more than 21.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,178 out of 14,244 | 22nd |
Division Manufacturing | 4,519 out of 5,765 | 22nd |
Major group Chemicals And Allied Products | 1,713 out of 2,128 | 20th |
Industry group Drugs | 1,453 out of 1,817 | 20th |
Industry Biological Products, Except Diagnostic Substances | 280 out of 339 | 17th |
Source: SEC filing on October 22, 2019.
Grint's colleagues
We found two more compensation records of executives who worked with Paul C. Grint at AmpliPhi Biosciences in 2018.